scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF02536136 |
P698 | PubMed publication ID | 1453884 |
P2093 | author name string | R. Saynor | |
T. Gillott | |||
P2860 | cites work | The composition of food consumed by Greenland Eskimos. | Q34066676 |
Suppression by diets rich in fish oil of very low density lipoprotein production in man. | Q34611154 | ||
A simple method based on broken-line interpolation for displaying data from long-term clinical trials | Q36652651 | ||
Prevention of coronary heart disease: the role of essential fatty acids | Q36716417 | ||
Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia | Q38582888 | ||
Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials | Q39731129 | ||
Evaluation of a rapid method for the determination of plasma fibrinogen | Q41227253 | ||
A hypothesis on the development of acute myocardial infarction in Greenlanders. | Q41554792 | ||
Plasma fibrinogen--a major coronary risk factor | Q41879314 | ||
The triglyceride issue: a view from Framingham | Q44822390 | ||
Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality | Q46216993 | ||
Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California | Q46362681 | ||
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. | Q54047035 | ||
Lipid Metabolism, Atherogenesis, and Haemostasis in Eskimos: the Role of the Prostaglandin-3 Family | Q66972822 | ||
The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers | Q67254951 | ||
Comparison of C18-, C20- and C22-unsaturated fatty acids in reducing fatty acid synthesis in isolated rat hepatocytes | Q67415059 | ||
Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia | Q68967200 | ||
Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study | Q68979773 | ||
Can the hypotriglyceridemic effect of fish oil concentrate be sustained? | Q69177089 | ||
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids | Q69836103 | ||
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina | Q70189648 | ||
Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
On the enzymatic method of neutral fat determination in biological matter | Q72187518 | ||
Identification of shellfish fatty acids and their effects on lipogenic enzymes | Q72427621 | ||
Eicosapentaenoic acid and platelet function in Japanese | Q72436275 | ||
Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: Pharmacological basis for a therapeutic approach | Q72854277 | ||
[A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method] | Q72966851 | ||
[A new determination of the neutral fats in blood serum and tissue. II. Reliability of the method, other neutral fat determinations, normal values for triglycerides and glycerin in human blood] | Q72966855 | ||
Molecular complexes in the isolation and characterization of plasma lipoproteins | Q78827425 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
fish oil | Q1786125 | ||
fortified food | Q66296884 | ||
P304 | page(s) | 533-538 | |
P577 | publication date | 1992-07-01 | |
P1433 | published in | Lipids | Q15756668 |
P1476 | title | Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years | |
P478 | volume | 27 |
Q74510523 | A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors |
Q44732136 | A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets |
Q54107230 | Comparison of the effects of two low fat diets with different alpha-linolenic:linoleic acid ratios on coagulation and fibrinolysis. |
Q42692520 | Current Complementary and Alternative Therapies for Multiple Sclerosis |
Q54142410 | Dietary fish oil as a photoprotective agent in hydroa vacciniforme. |
Q34099690 | Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis |
Q40752888 | Effects of fish oil on risk factors for cardiovascular disease. Minireview based on a doctoral thesis |
Q40744822 | Fibrinogen: an important risk factor for atherothrombotic diseases |
Q71329908 | Fish oil and other nutritional adjuvants for treatment of congestive heart failure |
Q52274072 | Fish oil may be an antidote for the cardiovascular risk of smoking. |
Q72540645 | Hematological and lipid changes in newborn piglets fed milk replacer diets containing vegetable oils with different levels of n-3 fatty acids |
Q51572238 | Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. |
Q33695216 | Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state |
Q47775284 | Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline |
Q24245810 | Omega 3 fatty acids for prevention and treatment of cardiovascular disease |
Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q30438647 | Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project |
Q40389357 | Omega-3 fatty acids. Current status in cardiovascular medicine |
Q37875207 | Omega-3 polyunsaturated fatty acids: photoprotective macronutrients |
Q41560071 | Pharmacological approaches and strategies for therapeutic modulation of fibrinogen |
Q36871266 | Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpina: summary of toxicological data |
Q45958676 | Safety evaluation of arachidonic acid rich Mortierella alpina biomass in albino rats--a subchronic study. |
Q35629424 | Significant inverse association of marine n-3 fatty acids with plasma fibrinogen levels in Japanese in Japan but not in whites or Japanese Americans. |
Q71177644 | Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion--the 'PKC syndrome' |
Q51573904 | Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake. |
Q35542194 | n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease |
Q41195338 | n-3 fatty acids and lipoproteins: comparison of results from human and animal studies |
Search more.